iSR’OBOT™ MONA LISA

Mona Lisa Biopsy

iSR’OBOT™ MONA LISA

This device fuses MRI with real-time ultrasound to generate 3D visualizations, enalbling precise targeting of suspected lesions during prostate biopsy and improving the detection rate of prostate cancer.

  • U.S. Food and Drug Administration (FDA) Approved in 2013
  • The Ministry of Food and Drug Safety (MFDS) Approved in August 2025
Robotic Accuracy
Mona Lisa’s navigational system ensures precise needle positioning and depth control for fast and accurate biopsy collection, even at the apex, anterior and peripheral areas.
Prostate Stability
Unlike conventional biopsy methods, the specially designed ultrasound probe cover stabilizes the prostate, preventing movement and enabling precise biopsy with minimal deformation.
Dual-cone Technology
Mona Lisa’s innovative dual-cone approach minimizes pubic arch interference, creating a virtual pivot point for multiple needle entries and ensuring maximal prostate coverage.